Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy
Abstract Context Toxicity-monitoring plays an important role in all cancer treatment, however, early recognition is vital for detecting and treating immune-related symptoms. Preparing a Patient Reported Outcomes tool and including melanoma patients receiving immunotherapy in the reporting of symptom...
Main Authors: | Lærke K. Tolstrup, Lars Bastholt, Ann-Dorthe Zwisler, Karin B. Dieperink, Helle Pappot |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-03-01
|
Series: | Journal of Patient-Reported Outcomes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41687-019-0111-8 |
Similar Items
-
The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial
by: Lærke K. Tolstrup, et al.
Published: (2020-10-01) -
A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy
by: Mille Guldager Christiansen, et al.
Published: (2023-07-01) -
Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial
by: Lærke K. Tolstrup, et al.
Published: (2022-01-01) -
Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
by: Minji K. Lee, et al.
Published: (2020-12-01) -
Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
by: Evalien Veldhuijzen, et al.
Published: (2020-10-01)